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Running Head: Information sharing and binding in FAD 
Abstract 
Background: Alzheimer’s disease (AD) as a disconnection syndrome disrupts both brain  
information sharing and memory binding functions. The extent to which these two phenotypic 
expressions are shared pathophysiological mechanisms remains unknown. Objective: To unveil 
the electrophysiological correlates of integrative memory impairments in AD towards new 
memory biomarkers for its prodromal stages. Methods: Patients with 100% risk of familial AD 
(FAD) and healthy controls underwent assessment with the VSTM binding test (VSTMBT) while 
we recorded their EEG. We applied a novel brain connectivity method (Weighted Symbolic 
Mutual Information) to EEG data. Results: Patients showed significant deficits during the 
VSTMBT. A reduction of brain connectivity was observed during resting as well as during correct 
VSTM binding, particularly over frontal and posterior regions. An increase of connectivity was 
found during VSTM binding performance over central regions. While decreased connectivity was 
found in cases in more advanced stages of FAD, increased brain connectivity appeared in cases 
in earlier stages. Such altered patterns of task-related connectivity were found in 89% of the 
assessed patients. Conclusions: VSTM binding in the prodromal stages of FAD are associated to 
altered patterns of brain connectivity thus confirming the link between integrative memory 
deficits and impaired brain information sharing in prodromal FAD. While significant loss of brain 
connectivity seems to be a feature of the advanced stages of FAD increased brain connectivity 
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characterizes its earlier stages. These findings are discussed in the light of recent proposals about 
the earliest pathophysiological mechanisms of AD and their clinical expression.  
Keywords: Alzheimer’s disease; Memory binding; Brain connectivity; Mutual Information; EEG; 
Biomarkers; PSEN1   
 
Introduction 
There is a need for affordable and reliable biomarkers for Alzheimer’s disease (AD) [1;2]. 
Electrophysiological tools are particularly appealing due to their low cost and growing robustness 
[3-5]. The present study investigates whether the impairment in visual short-term memory 
(VSTM) binding previously reported in familial AD (FAD) [6] is linked to abnormal brain 
information sharing mechanisms as informed by electrophysiological methods. We focused on 
brain connectivity analysis to unveil electrophysiological signatures of AD in the prodromal stages 
of the familial variant caused by the single mutation E280A of PSEN1 gene [7]. Such evidence 
would refine the theory about mechanisms of memory impairment in AD and would strengthen 
the reliability of this novel cognitive marker, making a case for a novel combined behavioural-
electrophysiological neurocognitive biomarker for AD. 
Both traditional and novel neuropsychological tasks assess context-rich memory functions linked 
to structures within the medial temporal lobe such as the hippocampus [8-12]. Memory functions 
relying on the functional integrity of the hippocampus decline early in the course of AD [13-15]. 
However, such functions also decline rapidly during healthy ageing [16]. This undermines the 
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specificity of such tasks and may delay the early detection of memory impairments in people who 
are likely developing AD. There is growing consensus that structures of the medial temporal lobe 
other than the hippocampus (i.e., entorhinal and perirhinal cortex), which support context-free 
memory functions, decline in early stages of AD recently described as sub-hippocampal stages 
[17;18]. Such regions have been found to be preserved throughout healthy ageing in both 
humans [19] and animal models [20]. 
The VSTM binding task complies with the definition of tests of the sub-hippocampal stages of AD 
[17]. VSTM binding has been found to be insensitive to healthy ageing [21-23] and very sensitive 
to AD [6;24;25]. Recent neuroimaging and neuropsychological studies confirmed that such a 
cognitive function can be carried out with a damaged hippocampus [26-29]. Moreover, VSTM 
binding declines in young asymptomatic carriers of the mutation E280A-PS1, which inevitably 
leads to the development of early-onset FAD [7], even when they still perform tasks of 
hippocampal functions without difficulties [6;30]. This evidence has led to the proposal that 
VSTM binding is an early cognitive marker for AD.  
Previous electrophysiological studies in presymptomatic carriers of the E280A-PS1 mutation have 
reported task-related activations which clearly distinguish between mutation carriers and non-
mutation carriers [31;32]. This evidence warrants similar investigation of VSTM binding, a 
function which has proved behaviourally sensitive to the otherwise asymptomatic stages of 
E280A-PS1 FAD [6;30]. Since the memory binding functions responsible for integrating visual 
features into unified objects require effective communication between specialised brain regions 
(e.g., colour and shape processing areas), and AD is known to disrupt information transfer 
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between brain regions, such investigation would benefit from a functional network connectivity 
approach [33]. Typically, in the VSTM binding task participants are asked to remember the link 
between objects’ features such as shapes and colours which are known to be processed in 
different brain regions. To form memory representations of such complex objects accurately, the 
brain regions involved in feature processing (e.g., shape and colour areas) should be effectively 
connected [34]. This task therefore offers the opportunity to explore, from an 
electrophysiological perspective, patterns of brain connectivity associated to memory binding. 
The analysis of brain connectivity opens up new opportunities to discover phenotypes of 
preclinical AD [35]. The two main approaches used to investigate patterns of brain connectivity, 
or lack thereof, in patients with AD are the analysis of resting-state (e.g., Default Mode Network 
–DMN) and task-related connectivity. Both have proved informative in the presymptomatic and 
prodromal stages of AD (e.g., [36-38]). Nevertheless, there remain some challenges to be met in 
order to enable a wider and more reliable use of this novel methodology. First, methods aimed 
at investigating brain connectivity in AD ought to have both sensitivity and specificity for this type 
of dementia. Second, such methods should prove robust when applied to EEG. 
The present study addressed the hypothesis that VSTM binding deficits in the prodromal stages 
of FAD are linked to measurable electrophysiological changes which can add reliability to this 
methodology in the early identification of the AD pathology. 
 
Methods 
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Participants 
Ten patients in the Mild Cognitive Impairment (MCI) stages of FAD (MCI- FAD) and ten healthy 
controls entered the study. They were recruited in large kindred from the Colombian province of 
Antioquia in South America. The MCI-FAD patients carry a gene mutation (i.e., E280A in the PSEN-
1 gene) that leads to early-onset familial Alzheimer’s disease (E-FAD) in 100% of carriers [7]. 
Healthy controls were recruited from the general population. At the time of assessment all the 
participants were having an active working life, were living independently and were off 
medication. Patients with MCI-FAD met the definition proposed by Acosta-Baena et al [39]. They 
were randomly selected from the database of the Neuroscience Group of Antioquia and had 
undergone a comprehensive clinical and neuropsychological assessment no longer than 6 
months prior to EEG assessment. MCI-FAD patients and controls did not significantly differ in age 
or years of education (see Table 1). All participants gave informed consent to take part in the 
study which was approved by the relevant Ethics Committees. 
 
Assessment 
Neuropsychological Battery 
The Neuropsychological Battery comprised the Mini Mental State Examination (MMSE) [40], 
Memory Impairment Screen [10] and Memory Capacity Test [41] which have been validated in 
this population [42], the brief version of the Boston Naming Test [43], Word List Learning from 
CERAD [44], Spanish version of Verbal Fluency Test (Category Animals, adapted from [45], the 
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Copy and Recall of the Complex Figure of Rey-Osterrieth [46;47], Part-A of the Trail Making Test 
(TMT) [48]. We also collected data from Instrumental Activities of Daily Living (IADL, [49]) and 
basic Activities of Daily Living (Barthel Index, [50]). 
 
The VSTM Binding Task 
The VSTM binding task was that reported by Parra et al. [6]. The task assessed VSTM for arrays 
of stimuli presented on a computer screen (Figure 1). Stimuli were randomly selected from a set 
of eight shapes and a set of eight colours and were presented either independently (i.e., VSTM 
for single features) or combined (i.e., VSTM binding). Each type of stimuli was presented in a 
separate condition. During the task, participants were presented with arrays of three items. The 
trial design for each condition of the VSTM task is shown in Figure 1. The task was based on a 
change detection paradigm. At the beginning there was a fixation screen for 1000 msec. This was 
followed by the study display which was presented for 500 msec. The study display presented 
three items as explained above. After the study display there was an unfilled retention interval 
of 900 msec which was followed by the test display. The participants had to recognise if the items 
presented in the test display were the same or different from those presented at study. In 50% 
of the trials the items were the same in both displays (i.e., “same trials”.) In the other 50%, two 
items in the test display were different (i.e., “different trials”). 
8 
 
 
Figure 1. The VSTM task (see description in text). 
One condition assessed VSTM for shapes and one assessed VSTM for shape-colour bindings. In 
the Shape Only condition, arrays of shapes were presented in the study display. In the test display 
for the “different trials”, two shapes from the study array were replaced with two new shapes 
which were randomly drawn from the set of shapes. Hence, only VSTM for individual shapes was 
required to detect a change. In the Shape-Colour Binding condition, combinations of shapes and 
colours were presented in the study display. In the test display for the “different trials” two 
shapes swapped the colours in which they had been shown in the study display. Hence, memory 
for bindings of shape and colour in the study display was required in order to detect this change. 
No shape or colour was repeated within a given array. Each condition consisted of a brief practice 
session using flashcards followed by 100 test trials per experimental condition (200 trials in total). 
The task for the participants was to detect when a change had occurred and to report orally 
‘same’ or ‘different’ as appropriate. Participants were instructed to respond when the 
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experimenter requested such responses. This procedure allowed the isolation of the artefact 
induced by verbal responses. The experimenter then entered participants’ responses using the 
keyboard. Trials were fully randomized across participants and conditions were delivered in a 
counterbalanced order. 
For the present study we chose to use Shape Only as the baseline condition instead of both Shape 
and Colour Only as reported in earlier studies [6;24]. Previous research has shown that memory 
for bindings is consistently defined by memory for the more challenging feature [26;51;52]. It is 
therefore revealing when this relationship between memory for bindings and memory for shapes 
is lost in AD. Colour, by contrast, has not been seen to constrain memory for bindings as 
consistently as shape has. Therefore, the shape-binding comparison presents a conservative and 
reliable indicator of an impairment that is outwith task difficulty, thus our use of it in the present 
study. 
 
EEG Recording 
EEG recording was carried out while participants performed the VSTM Binding task (Figure 1). 
EEG activity was collected with SynAmps 2.5 ® system from Neuroscan. A 64-channel Quick-Cap 
was used to acquire the signal with linked mastoids as the reference. EOG signal was collected 
with 4 electrodes (HEOR, HEOL, VEOL, and VEOU) to eliminate oculomotor artefacts. Impedances 
were kept below 10 KΩ. EEG signal was sampled at 500 Hz and filtered with a bandwidth of 1 -
200 Hz. A 50Hz notch filter was also used. The recording session consisted of approximately 30 
minutes corresponding to the VSTM Binding task and 10 minutes of eyes-closed resting state.  
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Analysis 
Behavioural 
For the VSTM task we calculated corrected recognition as the proportion of hits minus false 
alarms. These data were compared across the two groups using non-parametric Mann-Whitney 
U test (see also Supplementary Supplementary Figure 1). Only patients underwent full 
neuropsychological assessment. However, controls also received the Mini Mental State 
Examination (MMSE) to ascertain normality in this group. The patients’ demographic and 
neuropsychological data were compared to the control group or to available norms [53;54] using 
independent sample or one sample t-Tests, respectively. For each pairwise comparison we 
calculated the effect size (Cohen-d: 0.2 small, 0.5 medium and 0.8 large).  
 
Brain Connectivity 
Given that VSTM binding requires effective communication between regions of the brain 
responsible for integrating stimulus features, we used a new measure of integration and global 
information sharing across distant cortical regions, called Weighted Symbolic Mutual Information 
(wSMI) [55], adapted for active tasks assessment [56] (see Figure 2).  wSMI assesses the extent 
to which two signals present non-random joint fluctuations (sharing information) providing (a) a 
fast and robust estimation of the signals’ entropies, (b) detection of nonlinear coupling and (c) 
discarding spurious correlations between EEG signals arising from common sources (See [55]). 
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WSMI involves a symbolic transformation which depends on temporal separation (here, Tau-τ 
1=2 ms, 2=4 ms, 3=8 ms, 4=16ms or 5=32 ms) each of which is sensitive to information sharing at 
specific frequency bands [56]. wSMI was computed as follows [55]. First, EEG signals from each 
channel were transformed in a series of discrete symbols that were defined by the ordering of 
the amplitude values of k time samples with a temporal separation of τ. Then, the joint probability 
of each pair of symbols was estimated and the joint probability matrix was multiplied by binary 
weights. The weights were set to zero for identical or opposite symbols, as they could reflect 
common sources, on the same or opposite sides of a single electric dipole, respectively. Formally, 
wSMI was computed as: 
 
wSMI(Xˆ,Yˆ ) =
1
log(k!)
w(xˆ, yˆ)p(xˆ, yˆ)log
p(xˆ, yˆ)
p(xˆ)p(yˆ)
yˆÎYˆ
å
xˆÎXˆ
å  
 
where, x ̂ and ŷ are the symbols present in signals X̂ and Ŷ respectively; p(x)̂ and p(ŷ) are the 
probabilities of the symbols in each signal; p(x,̂ ŷ) the joint probability of co-occurrence of 
symbols x ̂and ŷ in signals X̂ and Ŷ respectively; k the number of symbols and w(x,̂ ŷ) the binary 
weight. 
The wSMI frequency specificity was estimated by King et al. [55] based on simulations, which 
were restricted to taus 4, 8, 16 and 32 ms. We have implemented the measure also adding tau = 
2 ms but without following estimation procedures. We were interested in extending our analysis 
to faster frequency domains. We calculated the median wSMI across all channel pairs for each τ.  
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This measure (i.e., wSMI) was applied to both resting-state and task-related EEG. The two 
approaches have proved differentially informative about of the impact of early pathological 
changes in the course of AD. For example Koch et al. [38] reported reduced connectivity in 
patients with prodromal AD relative to healthy controls over parietal regions during resting MRI 
but increased connectivity over the same region during an attention-demanding task. As the 
patients assessed here were also in the prodromal stages of FAD, we anticipated that a pattern 
similar to that previously found [38]  would be observed in the present study. Regarding task-
related connectivity, we performed analyses during the whole VSTM task (from encoding to 
retrieval). However, as AD is known to disrupt memory encoding more severely than memory 
retrieval we ran a second analysis for the encoding phase. Discrepancies between these analyses 
would suggest that the locus of connectivity impairments in MCI-FAD may reside either beyond 
memory encoding or expand across memory processes. Alternatively, new insights would be 
obtained into the encoding deficits hypothesis of AD [57] from a connectivity perspective. T-tests 
were carried out with the significance threshold set at 0.01 for within-group comparisons and at 
0.05 for between-group comparisons. In order to identify the most reliable differences, only the 
last quartile of the significant differences was reported and plotted for each tail of the t-Test 
distribution (see Figure 2).  
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Figure 2. Algorithm used to build the brain connectivity maps using wSMI data (see text for more 
information about this methodology).  
 
To better quantify the differences in short- and long-distance connections between groups, we 
used a Euclidian distance connectivity function among channels [55], and applied it to the 
different conditions of the VSTM task. These were obtained with the following equation. 
 
 𝑑𝑖,𝑗 =  √(𝑥𝑖 − 𝑥𝑗)
2
+ (𝑦𝑖 − 𝑦𝑗)
2
+(𝑧𝑖 − 𝑧𝑗)
2
 
 
Where x, y and z are the Cartesian spatial coordinates which define the Euclidean distance of 
each pair of electrodes. Thus, the function d describes in a linear correlation how the connectivity 
varies with increasing distance. The correlation function analysis allowed us to investigate the 
interaction between electrodes which are at a distance d (for all possible values of d), assessing 
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connectivity variations at different levels: at the small spatial level, we analysed electrodes in 
close proximity; at the large spatial level, we studied distant regional connectivity. This 
correlation function was calculated for each subject (and for all pairs of electrodes) and averaged 
within groups. To analyse the difference between conditions, we used non-parametric 
bootstrapping. 
In addition, in order to obtain an individual-based characterization of connectivity patterns [58], 
mean wMSI values from each patient were compared with a control group using a modified t-
Test [59-63]. For these analyses we calculated connectivity inter-ROI and intra-ROI. The 
motivation for selecting the ROIs was explained above. For inter-ROI comparisons, we calculated 
the average wSMI which included each individual electrode of one to-be-contrasted ROI with all 
the electrodes of the other ROI. These individual averages (i.e., per electrode) were then 
averaged out to calculate the inter-ROI wSMI. In the case of intra-ROI comparisons, it was the 
average connectivity between all the electrodes in that given ROI.  Multiple single-case statistics 
allows assessment of significant differences between multiple individual’s test scores and 
normative values derived from a small sample (i.e., 10 controls). This modified test is more robust 
for non-normal distributions and generates few type-I errors than other single case comparisons 
[59-63]. 
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Results 
Neuropsychological Data 
Mean data from the neuropsychological assessment is presented in Table 1. MCI-FAD Patients 
presented with an amnestic multiple-domain profile [39]. 
Table 1. Mean scores from MCI-FAD patients on the demographics, clinical and 
neuropsychological variables and results from the contrast carried out against controls or 
normative values. 
  
Norms/Controls 
(n=10) 
MCI-FAD 
(n=10) 
t-Test Effect Size 
Mean SD Mean SD t, p Cohen’s d 
Age a 44.3 5.6 44.4 3.2 0.05, n.s. 0.02 
Education a 11.3 13.9 7.3 4.1 0.87, n.s. 0.38 
MMSE a 29.1 1.1 25.2 4.5 2.75, 0.023 0.86 
IADL (Lawton) out of 8 b   7.2 1.0   
ADL (Barthel) out of 50 b   50.0 0.0   
MIS (A+B) c 7.2 1.2 3.8 2.5 4.04, 0.004 1.28 
MCT Cued List 1 c 14.9 1.4 10.9 3.5 3.23, 0.014 1.10 
MCT Cued List 2 c 12.9 2.7 5.5 3.4 6.19, <0.001 1.91 
MCT Cued List 1-2 List1 c 14.2 1.9 9.9 3.8 3.22, 0.015 1.07 
MCT Cued List 1-2 List2 c 13.2 2.7 5.9 3.6 5.75, 0.001 1.80 
Verbal Fluency (Animals) c 21.4 4.8 15.3 5.0 3.66, 0.006 1.02 
Boston Naming Test c 14.1 1.3 11.1 3.2 2.79, 0.024 0.90 
Word List Total Recall c 17.6 3.7 13.1 5.4 2.51, 0.037 0.75 
Word Delayed Recall c 6.68 1.64 3.89 2.76 3.03, 0.016 0.93 
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Word List Recognition c 9.65 0.61 7.22 3.56 2.04, n.s. 0.68 
TMT c 73.67 26.44 87.75 38.30 1.04, n.s. 0.33 
ROF Copy c 26.38 4.99 21.89 5.03 2.68, 0.028 0.73 
ROF Recall c 14.32 5.18 7.33 4.89 4.29, 0.003 1.14 
a Scores derived from the control group; b Abnormities are considered based on performance 
drop relative to the total scores. c Values from norms; IADL: Instrumental Activities of Daily Living; 
ADL: Activities of Daily Living; MCT: Memory Capacity Test; MIS: Memory Impairment Screen; 
TMT: Trail Making Test; ROF: Rey-Osterrieth Figure. 
 
Behavioural data from the VSTM Task 
FAD in its prodromal stages affected VSTM for bindings (Mann-Whitney U: 22.5, Z = -2.08, p = 
0.035, d=0.83) more pronnoucedly than VSTM for single features (Mann-Whitney U: 25.0, Z = -1. 
98, p = 0.063, d=0.85) (see Supplementary Figure 1 for more information on the behavioural 
data). 
 
EEG-Brain Connectivity  
Resting state connectivity 
Nine participants per group had their resting EEG recorded. As we aimed at investigating 
connectivity differences at the group and individual level in resting and task related EEG, we 
decided to include in this analysis only participants with both recordings (n=18). A pattern of 
higher connectivity was observed for the control group mainly in the 0-20Hz frequency band (τ = 
4 – 16 ms and 5 – 32ms, see Figure 3A), both when considering pairs of electrodes and each 
electrode relative to all the others electrodes. In the latter case, the differences were more 
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evident over centro-parietal and occipital electrodes (Figure 3B). Interestingly, Euclidian distance 
analysis showed that the significance of the differences found between patients and controls 
increases as a function of the distance (Figure 3C). For both groups wSMI values increased from 
2 cm to around 8 cm and then stabilized. 
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Figure 3. (A) wSMI for each τ across the whole scalp. Graphs show mean wSMI (Y axis) for each 
group plotted across the entire array of electrodes (X axis). From left to right electrodes 
correspond to frontal, central, and posterior regions. Shaded area represents standard deviation 
across subjects. (B) Connectivity topography. Mean wSMI for each channel (left: control subjects, 
right: patients). (C) Connectivity differences. Left: line plots showing the last quartile of 
differences meeting the significance threshold. Right: matrix of t values. The graphs illustrate 
stronger connectivity in controls than in MCI-FAD patients in slow frequency bands (τ = 4 – 16ms 
and 5 – 32ms) over central-parietal and posterior channels. (D) Functional connectivity as a 
function of distance between electrodes. Patients’ connectivity is remarkably lower between 
distant than neighbouring regions (* denotes contrasts reaching the significance threshold p 
<0.001). 
In order to verify whether abnormal connectivity is identifiable at a single subject level we ran a 
multiple case-based statistics using the Crawford t-Tests across 6 ROIs (Figure 4) (see methods 
for motivation to choose these ROIs and Supplementary Figure 2 for the full set of ROIs). This 
analysis revealed that reduced brain connectivity as assessed by wSMI characterizes all the 
patients that entered this analysis (Figure 4 A and B). 
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Figure 4. (A) Individual lines plots confirming patients’ reduced connectivity (i.e., wSMI) in the 
selected ROI, more remarkably over parietal-occipital electrodes [3-3 vs 4-4: t = 0.35, p=n.s.; 5-5 
vs 6-6: t = -1.506, p=n.s.; 3-3 vs 5-5: t = 16.092, p<0.001.; 3-3 vs 6-6: t = 18.375, p<0.001]. Such a 
decrease in functional connectivity accurately discriminated between MCI-FAD and healthy 
controls. (B) Outcomes from the statistics confirming that all the patients were correctly 
classified with high confidence. 
 
Task-related connectivity 
The analysis of the whole task yielded two main findings. The first and predicted one was a 
reduced brain connectivity associated to task performance in MCI-FAD cases relative to controls. 
This was noticeable in all the frequency bands (τ = 2-32ms) in both conditions of the VSTM task 
(Shape Only and Shape-Color Binding). However, as compared to healthy controls, MCI-FAD 
20 
 
patients showed higher connectivity density during the Shape Only condition than during Shape-
Color Binding condition (Figure 5). This reduction of brain connectivity in FAD-MCI was apparent 
over anterior and posterior brain regions. Of note, reduced network activity over anterior regions 
was rather unspecific as it characterized both Shape Only and Shape-Color Binding, whereas over 
posterior regions it was more specific to Shape-Color Binding. Decreased information transfer 
over frontal lobes characterized 3 out of the 9 patients who entered this analysis (see 
Supplementary Table 1). These patients were in more advanced stages of the disease as indicated 
by the MMSE (mean of patients with decreased connectivity: 21.0±4.4 vs. 26.8±3.7 for the 
remaining sample) and the cued recall task of MCT (5.7±1.5 vs. 12.0±2.8). The results from the 
analysis of the whole task mirrored those from the analysis involving the encoding phase only 
(Supplementary Figure 3), thus suggesting that impaired connectivity in MCI-FAD patients may 
originate during the early stages of memory processing (i.e., encoding). 
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Figure 5. Connectivity analysis during the two conditions of the VSTM task including the whole 
task (i.e., from encoding to test) and the two groups. Histogram and matrix of the t-test. Line 
plots showing the last quartile of differences meeting the significance threshold. 
 
The second and unpredicted finding was increased brain connectivity around central regions 
during the Shape-Color Binding condition (Figure 6A-B). Patients’ brain connectivity between 
neighboring regions within this large ROI was higher than that of controls. Of note, increased 
information transfer (i.e., wSMI) over such regions characterized 7 out of 9 patients whereas 
decreased information transfer within the same regions only characterized 1 patient (Figure 6C). 
In line with the first finding described above, brain connectivity decreased as the distance 
between regions increased and this was more noticeable during the Shape-Color Binding 
condition (Figure 6D). The pattern of brain connectivity between adjacent regions was higher in 
patients than in controls whereas for distant regions the opposite was observed particularly 
during the Shape-Colour Binding condition. 
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Figure 6. (A) wSMI data corresponding to the Shape-Colour Binding condition of the VSTM task 
(correct trials) across the two groups distributed over the scalp. MCI-FAD patients show values 
lower than controls in frontal and occipital electrodes but higher than controls in more central 
electrodes. (B) Electrodes showing increased brain connectivity in MCI-FAD patients relative to 
controls. (C) Case-based statistics [63] confirming that all but one patient (case 6 who was 
marginal) was correctly classified when either increased or decreased brain connectivity was 
considered. (D) Functional connectivity as a function of the distance between electrodes. 
Patients’ connectivity between adjacent regions was higher than that of controls whereas the 
opposite pattern was found between distant regions particularly during the Shape-Colour Binding 
condition (* denotes contrasts reaching the significance threshold p <0.001). 
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Discussion 
 
The present study was set out to investigate whether the well documented deficits in VSTM 
binding found in patients with sporadic [24;64] and familial AD [6;30] could be accounted for by 
altered brain information sharing mechanisms as revealed by the analysis of brain connectivity. 
We predicted that if such an association existed and was detectable via such a combined 
approach (i.e., task performance and EEG recording), this methodology would yield a novel 
memory biomarker for AD. We found that patients with the mutation E280A-PSEN-1 who showed 
a profile compatible with amnestic MCI based on a standard clinical and neuropsychological 
assessments, showed significant impairments in the VSTM Binding task. Due to sample size 
limitations, we could not rely on a mixed ANOVA model to test the hypothesis of selective binding 
deficits which have been previously reported in samples of sporadic and familial AD patients 
[6;24]. However, recent studies suggest that in MCI patients, such a dissociation (i.e., VSTM 
binding deficits >> VSTM deficits during  shape processing) may be contingent upon memory load 
[65]. Patients with MCI show the well documented pattern of selective VSTM binding deficits 
when they are assessed with visual arrays 2 items [65] but not with visual arrays of 3 items [65-
67]. Taken together these earlier findings and our current data, we feel confident to suggest that 
MCI patients who are already embarked on the neurodegenerative course of FAD, such as those 
assessed here, show a pattern of binding impairments akin to that seen in patients with mild AD. 
Future studies should consider assessing them with the task presenting visual arrays of 2 items 
(see also Supplementary Figure 1 for more information on these recent findings). 
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Brain connectivity analyses confirmed that such cognitive impairments originated mainly from 
abnormal brain activity in the low-frequency bands. Resting state analysis showed a significant 
decrease in brain connectivity which was found at the single subject level in the entire sample of 
patients. Task related connectivity (i.e., VSTM Binding task) yielded mixed findings. Significantly 
reduced connectivity was found in patients relative to controls over frontal and posterior regions 
but increased connectivity was observed over central regions during correct trials. Abnormal 
task-related connectivity over central regions was found in 89% of the assessed patients. 
Previous studies in asymptomatic carriers of the mutation E280A-PSEN-1 have reported deficits 
in VSTM binding in the absence of other memory impairments including associative memory 
[6;30]. The mutation carriers assessed in the present study were in more advanced stages of the 
disease process [38] than those assessed in earlier studies. In the current sample, VSTM binding 
deficits were accompanied by associative memory impairments (i.e., MIS, MCT). Recent studies 
have reported on the usefulness of associative memory task such as the MCT in the early 
detection of AD [68]. However, taken together the results from previous studies and the present 
study, we can argue that VSTM binding deficits anticipate associative memory impairments. This 
evidence seems to fit well recent hypotheses about the sequence of pathological changes in the 
course of AD [17]. Didic et al. [17] hypothesised that AD first undergoes a sub-hippocampal stage 
during which context-free memory functions (e.g., familiarity based recognition, object 
recognition) supported by extra-hippocampal regions (e.g., perirhinal and entorhinal cortex) are 
affected. This is followed by the hippocampal stage during which context-rich memory functions 
such as associative memory start to decline reflecting the impact of AD on the hippocampus. The 
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hippocampal stage of AD appears to correspond to the Braak stage III which clinically expresses 
as MCI [17]. 
A recent fMRI study with healthy young volunteers showed that the network supporting 
performance during the VSTM task involves occipito-temporal regions seemingly involved in 
feature processing (i.e., shapes and colours) and posterior parietal regions specifically supporting 
feature binding [26]. This earlier study failed to find hippocampal related activity during feature 
binding either during whole-brain or ROI-based analysis. 
As it was predicted in the current study, poor VSTM binding functions in MCI-FAD are the result 
of impaired connectivity between relevant brain regions. Brain connectivity analysis during 
resting state and task performance confirmed that parietal-occipital regions are a locus of early 
pathological changes in the course of E280A-FAD. The EEG literature reporting reduced brain 
connectivity in AD during resting state is growing rapidly [69-71]. In the present study we adapted 
a new measure of integration and global information sharing across distant cortical regions (i.e., 
wSMI) [55]). This method proved robust to discriminate between patients with different states 
of consciousness in an earlier study and then was adapted for successfully tracking short-time 
connectivity during active tasks [56]. The current study is the first one reporting the use of wSMI 
in FAD. Of note, this method is particularly suited to address question about the binding problem 
as it allows investigation of information sharing across distant brain regions, a cornerstone of 
cognitive binding [72;73]. By applying this method to resting state EEG, we were able to find 
abnormal patterns of brain connectivity in all the cases that entered the analysis. Previous studies 
investigating resting state connectivity in AD have achieved sensitivity values of 72–85% and 
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specificity of 77–80% [74-76], perhaps reflecting the heterogeneity of non-genetic variants. Our 
results suggest that during resting state, connectivity mediated by long tracts is the most 
discriminative between MCI-FAD patients and Controls. Earlier studies which analysed cerebral 
coherence during resting state reported an association between reduced long-tract connectivity 
and clinical progression of AD [77] (see also [78;79]). However, similar findings were reported by 
King et al. [55] in patients with different levels of consciousness, thus suggesting that connectivity 
problems during resting state may sensitive but not be specific for clinical purposes (see also 
[80]). 
A potential solution to this caveat is to identify the pattern of brain connectivity associated to 
performance on the VSTM Binding task which has proved both sensitive and specific to AD 
[64;81]. Such an analysis revealed a network which comprises frontal, central, and parietal-
occipital regions. The pattern of connectivity shown by these regions during the different 
conditions of the VSTM Binding task suggests that they may serve different functions. In healthy 
controls, the frontal regions showed increased connectivity during correct recognition of both 
Shape Only and Shape-Colour Binding. However, the parietal-occipital regions showed a pattern 
of connectivity specific to Shape-Colour Binding. Whereas the frontal regions appear to form part 
of the network subserving general working memory functions, the parietal-occipital regions are 
seemingly serving as the feature binding hub [82-84]. This evidence closely follows previous fMRI 
studies with healthy young volunteers which found binding-specific activation over parietal-
occipital regions ([26] see also [84-86]). Such a network organization observed in healthy controls 
was missing in MCI-FAD patients, particularly in the slow frequency bands (tau = 5 - 32ms). MCI-
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FAD patients showed a pattern of connectivity more compatible with a random network (see [87] 
for similar results using fMRI). 
In contrast to the reduced functional connectivity observed in MCI-FAD patients in anterior and 
posterior nodes of the task-related network, increased connectivity was found in this group 
relative to healthy controls over central regions (see Figure 6). Interestingly, a better classification 
power in patients was achieved by increased connectivity than by decreased connectivity (see 
Supplementary Table 1). It is worth noting that compared to other brain pathologies (e.g., 
stroke), neurodegeneration can trigger atrophy-related hyperconnectivity [88]. This has been 
previously confirmed in AD [89;90]. These results add to the array of evidence confirming 
functional reorganization in E280A-PSEN1 mutation carriers at stages of the disease prior to 
diagnosis of dementia [31;32;91;92]. Such compensatory changes have also been observed in the 
course of late-onset sporadic AD in patients who are either in the Subjective Cognitive Deficits – 
SCD [93;94], in the MCI [95-98], or in the early stages of dementia ([99]; see also [100] for a recent 
meta-analysis). They have been interpreted as a maladaptive reorganization of brain functions 
which detrimentally contributes to cognitive functioning. Compensatory changes are also found 
in the normal course of ageing (i.e., Scaffolding Theory of Cognitive Ageing) [101-104]. Therefore, 
in populations at risk for late-onset sporadic AD it would be difficult to tease apart the 
contributions of normal and abnormal ageing to such compensatory changes. However, 
confounding factors such as age and comorbidities are not present in the population investigated 
here. This grants us more confidence that the functional reorganization found in this and in 
earlier studies involving this population more genuinely reflects AD related mechanisms. Such a 
reorganization was representative of the majority of patients investigated here, indicating that 
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this is a rather phenotypic feature of MCI in the course of FAD. In fact, recent studies carried out 
in the same population confirmed that the functional reorganization in asymptomatic mutation 
carriers can be observed as early as a mean age of 13.7±2.6 [36]. Taken together the results from 
these studies suggest that functional network reorganization, as indicated by increased 
connectivity, may reflect the early stages of the disease process. However, decreased 
connectivity may reveal more advanced stages. 
In the light of the results reported here one may argue that just relying on resting state 
connectivity would suffice to achieve a correct identification of MCI-FAD cases (see for example 
[105]). Resting state connectivity alterations in AD have been interpreted as Default Mode 
Network (DMN) abnormalities [75;106]. Dysfunction of the DMN has been observed in a wide 
variety of neurological and psychiatry disorders [107]. From this perspective, DMN connectivity 
in the context of dementia assessment may resemble the MMSE, both are sensitive but non-
specific. However, the increased task-related connectivity found in this study indicates the 
presence of impaired-compensated networks which have been associated to the Aβ-pathology 
in the prodromal stages of AD [38]. This impaired connectivity is linked to a memory impairment 
(i.e., binding) known to be sensitive and also specific to both sporadic and familial AD. One might 
question the extent to which the results presented here are representative of AD more generally 
or just of this rare genetic variant due to the mutation E280A-PSEN1. We have recently 
demonstrated that cases of prodromal sporadic and familial AD share a common behavioral and 
electrophysiological phenotype when it comes to VSTM binding [66]. Earlier behavioral studies 
compared cases diagnosed with dementia due to sporadic and familial AD using a visual VSTM 
Binding test [30]. The authors reported that based on performance they could not distinguish 
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between the two variants of AD even though the familial cases were younger patients from 
Colombia who had low educational level and the sporadic cases were older adults form the UK 
with high educational attainment [30]. This evidenced grants us confidence to suggest that the 
deficits we are observing here characterize AD generally regardless of its clinical variant (i.e., 
familial or sporadic). 
A limitation of the present study is the small sample size. To reduce the impact of such limitation 
we adopted a statistical approach (i.e., multiple single-case statistics) that allowed us to confirm 
effects at the individual level. This approach evaluated in a small sample of patients with 100% 
probability of developing AD grants reliability to our findings. Future studies should confirm if the 
findings reported here hold with larger samples of MCI-FAD patients. Another limitation is that 
the low and high frequency ranges covered by the τ values calculated in our study are too 
widespread. In fact, such bands are far too broad to detect standard functional brain oscillations 
within specific frequencies and their link to physiological states. Nevertheless, abnormal 
oscillatory activity in AD has been reported for a wide range of frequencies ranging from low to 
high bands [90]. Thus, the decision of using a measure of information sharing which relies on a 
broad-band approach covering low (τ = 32ms) and high (τ = 4ms) EEG frequencies may be 
considered a more feasible methodology to characterize aberrant oscillations in the prodromal 
course of FAD (see also ([91]). 
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Conclusions  
 
By applying the analysis of a novel connectivity method to EEG data collected during VSTM 
binding performance from carriers of the mutation E280A-PSEN1 who inevitably develop FAD we 
have identified electrophysiological signatures of the impairment found in this memory function. 
This is the first study confirming the role of brain information sharing in VSTM binding functions 
and the disruption of such mechanisms as the underlying physiopathology of integrative memory 
deficits found in FAD. Such a disruption may be informed either by patterns of increased or 
decreased connectivity. They appear to account for poor task performance at different stages of 
the disease process. This biological evidence further strengthens the theory supporting this novel 
memory task and confirms its potential value as a memory biomarker for AD. 
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Supplementary Figure 1. Mean performance during the VSTM task. 
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Due to the small sample size we found it risky to rely on a mixed ANOVA model to test the 
hypothesis of selective binding deficits as a null finding would be difficult to interpret (i.e., limited 
power). Our most recent work suggests that the selectivity of binding impairments in patients 
with MCI might be contingent upon memory load [1]. Following the results reported by [2], who 
observed selective binding deficit in patients with Subjective Cognitive Decline (SCD) but not in 
patients with MCI, we have demonstrated that with high memory load, the latter group will show 
poor performance on both conditions of the VSTM task, shape only and shape-colour binding [1]. 
Previous studies reporting on the sensitivity and specificity of VSTM binding for AD, we used 
titration procedures [3-6]. That is, patients who met criteria for AD dementia were assessed with 
a version of the task that presented 2 items and controls or asymptomatic carriers of a mutation 
leading to familial AD [4] were tested with a version of the task that presented 3 items. Under 
these testing conditions, patients’ and controls’ performance on single feature conditions (i.e., 
shape only) was kept at the same level, and a selective impairment in binding was revealed in 
patients. Titration is difficult to undertake in clinical settings. We have started to assess patients 
and controls with the same task ([1] see also [7]). Our most recent work suggests that 3 items 
may already overload VSTM in MCI patients masking the selectivity of STM binding. As the data 
presented here suggest, binding performance in near ceiling while shape performance drops 
relative to controls, but is still off-ceiling. Pietto et al. [8] have recently reported very similar 
findings. Together, these results suggest that when such a selectivity is a desired outcome, 
patients with MCI should be tested with a smaller set size (i.e., 2 items version of the task). 
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Supplementary Figure 2. Topology of the ROIs explored during the resting state connectivity 
analysis. 
49 
 
 
 
Supplementary Figure 3. Connectivity analysis during the encoding phase of the two conditions 
of the VSTM task in the two groups. Histogram and matrix of the t-test. Line plots showing the 
last quartile of differences meeting the significance threshold. These results mirror those found 
during the whole task analysis (see manuscript for a full description of the results).   
50 
 
Supplementary Table 1. Case-based statistics [9-12] contrasting mean wSMI from ROI showing 
reduced connectivity in patients relative to controls over frontal regions in the two frequency 
bands (tau) which showed the best classification power. The outcomes identified 3 cases with a 
significant decrease in brain connectivity (wSMI). Such cases were among those with the lowest 
scores on the MMSE and on the cued recall of the Memory Capacity Test (MCT, [13]), thus 
suggesting more advanced stages of the disease process. 
    P1 P2 P3 P4 P5 P6 P7 P8 
TAU 4 
t 4.051 -3.698 0.581 -0.661 0.108 -0.790 -0.156 1.414 
p 0.998 0.003 0.711 0.264 0.542 0.226 0.440 0.902 
TAU 5 
t 2.415 -2.393 1.481 2.111 -2.393 -1.756 -0.412 -0.188 
p 0.979 0.022 0.912 0.966 0.022 0.059 0.346 0.428 
MMSE 29 23 24 21 16 30 27 30 
MCT-Cued Recall List 1 14 4 8  - 7 14 10 14 
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